LV10862B - Novel phenylethyl and phenylpropylamines - Google Patents

Novel phenylethyl and phenylpropylamines Download PDF

Info

Publication number
LV10862B
LV10862B LVP-95-156A LV950156A LV10862B LV 10862 B LV10862 B LV 10862B LV 950156 A LV950156 A LV 950156A LV 10862 B LV10862 B LV 10862B
Authority
LV
Latvia
Prior art keywords
compound
general formula
hydrogen
branched
amino
Prior art date
Application number
LVP-95-156A
Other languages
English (en)
Latvian (lv)
Other versions
LV10862A (lv
Inventor
Stefan Bengtsson
Sven Hellberg
Nina Mohell
Lian Zhang
Gerd Margareta Hallnemo
David Jackson
Bengt Ulff
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10862A publication Critical patent/LV10862A/xx
Publication of LV10862B publication Critical patent/LV10862B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/40—2,5-Pyrrolidine-diones
    • C07D207/404—2,5-Pyrrolidine-diones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. succinimide
    • C07D207/408—Radicals containing only hydrogen and carbon atoms attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
    • C07C2602/44—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing eight carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Luminescent Compositions (AREA)
LVP-95-156A 1993-10-07 1995-06-05 Novel phenylethyl and phenylpropylamines LV10862B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303274A SE9303274D0 (sv) 1993-10-07 1993-10-07 Novel phenylethyl and phenylproplamines
PCT/SE1994/000860 WO1995009835A1 (en) 1993-10-07 1994-09-16 Novel phenylethyl and phenylpropylamines

Publications (2)

Publication Number Publication Date
LV10862A LV10862A (lv) 1995-10-20
LV10862B true LV10862B (en) 1996-08-20

Family

ID=20391336

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-95-156A LV10862B (en) 1993-10-07 1995-06-05 Novel phenylethyl and phenylpropylamines

Country Status (31)

Country Link
US (1) US5693630A (sk)
EP (1) EP0672032B1 (sk)
JP (1) JPH08504835A (sk)
KR (1) KR950704236A (sk)
CN (1) CN1048718C (sk)
AT (1) ATE161823T1 (sk)
AU (1) AU680303B2 (sk)
BR (1) BR9405632A (sk)
CA (1) CA2150005A1 (sk)
CZ (1) CZ148595A3 (sk)
DE (1) DE69407751T2 (sk)
DK (1) DK0672032T3 (sk)
EE (1) EE03214B1 (sk)
ES (1) ES2111959T3 (sk)
FI (1) FI952772A0 (sk)
GR (1) GR3026484T3 (sk)
HU (1) HUT73774A (sk)
IL (1) IL111133A (sk)
IS (1) IS4204A (sk)
LT (1) LT3920B (sk)
LV (1) LV10862B (sk)
NO (1) NO305947B1 (sk)
NZ (1) NZ274273A (sk)
PL (1) PL179011B1 (sk)
RU (1) RU2133735C1 (sk)
SE (1) SE9303274D0 (sk)
SI (1) SI9420007A (sk)
SK (1) SK67295A3 (sk)
TW (1) TW338036B (sk)
WO (1) WO1995009835A1 (sk)
ZA (1) ZA947209B (sk)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4071000B2 (ja) * 2000-05-25 2008-04-02 エフ．ホフマン−ラ ロシュ アーゲー 置換１−アミノアルキルラクタム及びムスカリン受容体アンタゴニストとしてのそれらの使用
RU2320336C2 (ru) * 2001-09-12 2008-03-27 Мерк Патент Гмбх Новое применение замещенных аминометилхроманов для лечения нарушений движений или нежелательных действий, вызываемых средствами, которые вводятся для лечения экстрапирамидных нарушений движений
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
IL157751A0 (en) 2003-02-28 2004-03-28 Yissum Res Dev Co New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid, a method for their synthesis and pharmaceutical compositions containing them
IL156203A0 (en) * 2003-05-29 2003-12-23 Yissum Res Dev Co Use of 2,2,3,3, tetramethylcyclopropane carboxylic acid derivatives for treating psychiatric disorders

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR7644E (fr) 1903-08-11 1907-09-17 Chappee Et Fils Soc Nouveau système d'assainissement des villes
DE1518375A1 (de) * 1965-06-08 1969-08-14 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen 2-Amino-halogenbenzylaminen
FR7644M (sk) * 1968-06-24 1970-02-02
DE2345423A1 (de) * 1973-09-08 1975-03-20 Thomae Gmbh Dr K Neue substituierte phenylaethylaminderivate, deren saeureadditionssalze, diese enthaltende arzneimittel sowie verfahren zu deren herstellung
US4021558A (en) * 1973-09-08 1977-05-03 Boehringer Ingelheim Gmbh 1,3-Dioxo-2-[(methoxyphenethyl-amino)-alkyl]-4,4-dimethyl-isoquinolines and salts thereof useful as hypotensive agents
AT330777B (de) * 1973-09-08 1976-07-26 Thomae Gmbh Dr K Verfahren zur herstellung von neuen isochinolinderivaten und deren salzen
JPS5414956A (en) * 1977-07-04 1979-02-03 Sumitomo Chem Co Ltd Novel 3-amino-4-homoisotwistan derivative
DE3119874A1 (de) * 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4490369A (en) * 1981-05-19 1984-12-25 Dr. Karl Thomae Gesellschaft Mit Beschrankter Haftung Benzazepine derivatives, their pharmaceutical compositions and method of use
FR2608157B1 (fr) * 1986-12-11 1989-09-08 Roussel Uclaf Nouveaux derives de l'azaspirodecane, leurs sels, procede de preparation, application a titre de medicaments et compositions les renfermant et intermediaires
ATE63399T1 (de) 1986-12-12 1991-05-15 Sediver Verfahren zur herstellung eines blitzableiters und durch dieses verfahren hergestellter blitzableiter.

Also Published As

Publication number Publication date
NO952232L (no) 1995-07-18
RU95112451A (ru) 1997-04-20
ES2111959T3 (es) 1998-03-16
FI952772A (fi) 1995-06-06
BR9405632A (pt) 1999-05-25
US5693630A (en) 1997-12-02
HUT73774A (en) 1996-09-30
NO305947B1 (no) 1999-08-23
DE69407751D1 (de) 1998-02-12
NZ274273A (en) 1996-10-28
ATE161823T1 (de) 1998-01-15
DE69407751T2 (de) 1998-04-16
HU9501643D0 (en) 1995-08-28
DK0672032T3 (da) 1998-05-04
IL111133A0 (en) 1994-12-29
GR3026484T3 (en) 1998-06-30
AU7825694A (en) 1995-05-01
RU2133735C1 (ru) 1999-07-27
EP0672032A1 (en) 1995-09-20
LT95059A (en) 1995-10-25
CN1115575A (zh) 1996-01-24
WO1995009835A1 (en) 1995-04-13
EE03214B1 (et) 1999-08-16
NO952232D0 (no) 1995-06-06
IL111133A (en) 1998-12-27
LV10862A (lv) 1995-10-20
SE9303274D0 (sv) 1993-10-07
EP0672032B1 (en) 1998-01-07
KR950704236A (ko) 1995-11-17
AU680303B2 (en) 1997-07-24
SI9420007A (en) 1996-04-30
PL309189A1 (en) 1995-09-18
IS4204A (is) 1995-04-08
FI952772A0 (fi) 1995-06-06
LT3920B (en) 1996-04-25
JPH08504835A (ja) 1996-05-28
CZ148595A3 (en) 1996-01-17
PL179011B1 (pl) 2000-07-31
CA2150005A1 (en) 1995-04-13
ZA947209B (en) 1995-07-07
SK67295A3 (en) 1996-09-04
TW338036B (en) 1998-08-11
CN1048718C (zh) 2000-01-26

Similar Documents

Publication Publication Date Title
EP0447285B1 (fr) Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
RU2119917C1 (ru) Производные пиразола, способ их получения, содержащая их фармацевтическая композиция и промежуточные соединения синтеза
AU638096B2 (en) Novel benzimidazole and azabenzimidazole derivatives which are thromboxane receptor antagonists, their methods of preparation, synthesis intermediates and pharmaceutical compositions in which they are present
EP2456754B1 (fr) Derives d'acyl-guanidines modulateurs de la voie de signalisation des proteines hedgehog
PT98100A (pt) Processo para a preparacao de novos compostos do acido 4-amino-butirico e de composicoes farmaceuticas que os contem
EP0779284B1 (fr) Nouveaux dérivés de 2-naphthamides et leurs applications thérapeutiques comme agonistes des récepteurs D3
WO2017131149A1 (ja) テトラヒドロナフタレン誘導体
WO1998045242A1 (fr) Regulateurs d'activite des retinoides
LV10862B (en) Novel phenylethyl and phenylpropylamines
FR2664269A1 (fr) Nouveaux derives n-substitues d'alpha-mercapto alkylamines, leur procede de preparation, leur application a titre de medicaments et les compositions les renfermant.
EP0740658A1 (de) N-substituierte azabicycloheptan-derivate wie z.b. neuroleptika
US5753690A (en) N-substituted azobicycloheptane derivatives, the preparation and use thereof
BG62349B2 (bg) N-заместени производни на 3-азабицикло/3.2.0/хептан като невролептици
JP2005512986A (ja) 置換１ｈ−キノキサリン−２−オン化合物ならびに置換４−アリール−および４−ヘテロアリールシクロヘキサン化合物
TW200846328A (en) GlyT1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
CA1062265A (fr) Procede de preparation de nouvelles benzylamines
CA1052788A (fr) Procede d'obtention de nouveaux acetamides n-substitues et les composes ainsi obtenus
US5093355A (en) Benzylpyrrolidine derivatives as dopamine agonists
TW200534846A (en) Compounds useful for the treatment of diseases
FR2677016A1 (fr) Nouveaux derives d'amide antagonistes des recepteurs a l'angiotensine ii; leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2672595A1 (fr) Nouveaux derives bicycliques azotes substitues par un radical benzyle, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments.